Other News To Note
Thursday, August 9, 2012
• Cynapsus Therapeutics Inc., of Toronto, received a grant of $947,925 from the Michael J. Fox Foundation for Parkinson's Research for development of APL-130277, a reformulation of apomorphine for sublingual delivery.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.